Thomas Rowland's Insider Trades & SAST Disclosures

Thomas Rowland's most recent trade in ANI Pharmaceuticals Inc was a trade of 627 Common Stock done at an average price of $61.9 . Disclosure was reported to the exchange on Feb. 28, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
ANI Pharmaceuticals Inc
Thomas Rowland SVP, HEAD - ESTABLISHED BRANDS Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. 28 Feb 2025 627 45,465 (0%) 0% 61.9 38,805 Common Stock
ANI Pharmaceuticals Inc
Thomas Rowland SVP, HEAD - ESTABLISHED BRANDS Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2025 7,834 41,452 (0%) 0% 0 Common Stock
ANI Pharmaceuticals Inc
Thomas Rowland SVP, HEAD - ESTABLISHED BRANDS Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2025 5,222 46,674 (0%) 0% 0 Common Stock
ANI Pharmaceuticals Inc
Thomas Rowland SVP, HEAD - ESTABLISHED BRANDS Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. 12 Feb 2025 582 46,092 (0%) 0% 58.9 34,291 Common Stock
ANI Pharmaceuticals Inc
Thomas Rowland SVP, HEAD - ESTABLISHED BRANDS Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.58 per share. 15 Nov 2024 867 33,169 (0%) 0% 56.6 49,055 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades